Iovance Biotherapeutics Inc (IOVA)
Financing Cash Flow
$287.85M
TTM · Period ending: · USD
IOVA Financing Cash Flow
Latest reported$287.85Mperiod ending
Latest reported$287.85Mperiod ending
IOVA TTM Cash from Financing ($0.00 → $287.85M)
TTM financing cash flow
High-resolution chart · PNG
IOVA financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 287,851,000 | |
| 251,793,000 | |
| 300,773,000 | |
| 246,910,000 | |
| 200,808,000 | |
| 340,403,000 | |
| 390,664,000 | |
| 389,317,000 | |
| 550,163,000 | |
| 398,363,000 | |
| 462,959,000 | |
| 652,572,000 | |
| 449,997,000 | |
| 446,905,000 | |
| 190,150,000 | |
| 3,725,000 | |
| 24,272,000 | |
| 190,321,000 | |
| 239,268,000 | |
| 238,076,000 | |
| 218,470,000 | |
| 622,953,000 | |
| 576,422,000 | |
| 575,552,000 | |
| 575,050,000 | |
| 9,966,000 | |
| 6,131,000 | |
| 243,388,000 | |
| 254,746,000 | |
| 254,725,000 | |
| 424,307,000 | |
| 187,861,000 | |
| 231,893,000 | |
| 227,885,000 | |
| 58,688,000 | |
| 56,005,000 | |
| 445,000 | |
| 97,287,000 | |
| 97,200,000 | |
| 97,259,000 | |
| 98,474,012 | |
| 7,950,912 | |
| 78,267,000 | |
| 110,452,422 | |
| 109,381,755 | |
| 105,531,835 | |
| 35,462,247 | |
| 24,797,388 | |
| 24,159,043 | |
| 23,589,573 | |
| 23,347,073 | |
| 1,551,510 | |
| 1,816,510 | |
| 1,781,250 | |
| 1,731,250 | |
| 4,101,250 | |
| 6,131,250 | |
| 5,743,000 | |
| 5,488,000 | |
| 3,981,137 | |
| 2,386,137 | |
| 1,540,000 | |
| 1,905,017 | |
| 1,041,880 | |
| 341,880 | |
| 360,017 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |